Skip to main content
Clinical Trials/NCT02995863
NCT02995863
Completed
Not Applicable

Clinical Efficacy of Therapeutic Footwear With a Rigid Rocker Sole in the Prevention of Reulceration in Patients With Diabetes Mellitus and Diabetic Polineuropathy: a Prospective and Randomized Clinical Trial.

Universidad Complutense de Madrid1 site in 1 country73 target enrollmentDecember 10, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetic Foot
Sponsor
Universidad Complutense de Madrid
Enrollment
73
Locations
1
Primary Endpoint
Presence of diabetic foot ulcer
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This research presents a randomized clinical trial which analyzes the efficacy of a rigid rocker sole in the reduction of the recurrence rate of plantar ulcers in diabetic foot patients. The hypothesis of the research is the use of a rigid rocker sole reduces the recurrence rate of diabetic foot ulcers in patients with peripheral neuropathy.

Registry
clinicaltrials.gov
Start Date
December 10, 2016
End Date
May 10, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mateo López Moral

Clinical Research

Universidad Complutense de Madrid

Eligibility Criteria

Inclusion Criteria

  • Type 1 or 2 diabetic patients regardless of the pharmacotherapy that they receive.
  • Adult patients of both sexes.
  • Peripheral neuropathy patients.
  • Patients without wounds or ulcers at the examination time.
  • Patients with a foot ulcers history.
  • Patients with or without minor amputation prior to the inclusion time in the present study.
  • Patients who don´t need gait support mechanisms such as walking sticks, crutches, splints or any other devices which interferes with the autonomous development of the gait.

Exclusion Criteria

  • Patients with mayor amputation.
  • Patients with rheumatic disease that affect the feet.
  • Patients with peripheral neuropathy of different etiology to Diabetes mellitus.
  • Patients with several critical ischemia criteria, defined by TACS II guideline.

Outcomes

Primary Outcomes

Presence of diabetic foot ulcer

Time Frame: through study completion, an average of 6 months

The Wagner system assesses ulcer depth and the presence of osteomyelitis or gangrene using the following grades: grade 0 (pre- or post-ulcerative lesion), grade 1 (partial/full-thickness ulcer), grade 2 (probing to tendon or capsule), grade 3 (deep with osteitis), grade 4 (partial foot gangrene) and grade 5 (whole foot gangrene

Secondary Outcomes

  • Ankle Joint movility(through study completion, an average of 6 months)
  • Mobility of the First metatarsal Joint(through study completion, an average of 6 months)
  • IPAQ (International Physical Activity Questionnaires)(through study completion, an average of 6 months)
  • Deformities(through study completion, an average of 6 months)
  • Subtalar Joint Movements(through study completion, an average of 6 months)
  • Ankle - Brachial Index (ABI)(through study completion, an average of 6 months)
  • Physical Activity Questionnaire(through study completion, an average of 6 months)
  • Foot Type(through study completion, an average of 6 months)
  • Toe - Brachial Index (TBI)(through study completion, an average of 6 months)
  • Sensorimotor neuropathy(through study completion, an average of 6 months)

Study Sites (1)

Loading locations...

Similar Trials